Skip to content

Nano Fat Injection With or Without Fractional Carbon Dioxide Laser in Acne Scars

Assessment of Nano Fat Grafting Combined With Fractional Carbon Dioxide Laser Resurfacing Versus Nano Fat Grafting Alone in Atrophic Facial Acne Scars

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05985265
Enrollment
50
Registered
2023-08-14
Start date
2023-09-01
Completion date
2024-05-29
Last updated
2023-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Scars - Atrophic

Brief summary

Assessment of nano fat grafting combined with carbon dioxide laser resurfacing versus nano fat grafting alone in treating facial atrophic acne scars

Detailed description

Acne scars is a world wide problem .though lots of treatment exists still mo gold standard for treatment of acne scars in this study. Assessment of nano fat grafting combined with carbon dioxide laser resurfacing versus nano fat grafting alone in treating facial atrophic acne scars

Interventions

PROCEDUREFat grafting

Nano fat grafting followed by fractional carbon dioxide laser resurfacing

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* patients older than 18 years who attend the Outpatient Clinics of Dermatology and Plastic Surgery Departments, Assiut University Hospital, with moderate to severe atrophic facial acne scars on both cheeks, as assessed using the Goodman and Baron Qualitative scar grading system (12), will be enrolled in the study.

Exclusion criteria

* include: pregnancy or lactation; active acne, history of deep chemical peeling or filler injection in the previous 6 months, history of keloid or hypertrophic scar formation; use of isotretinoin in the previous 6 months; active infection in the treatment area; bleeding tendencies; history of herpes simplex or herpes zoster infection on the face; and patients with unrealistic expectations.

Design outcomes

Primary

MeasureTime frameDescription
Clinical assessment of acne scar severityup to 24 weeksas assessed using the Goodman and Baron Qualitative scar grading system before and after treatment on both sides of face, to determine the number of patients achieving two grades improvement vs one grade or no improvement

Secondary

MeasureTime frameDescription
Physician global assessmentup to 24 weekstwo blinded observers will compare the before and after photographs separately on each facial side and will evaluate the improvement on a quartile grading scale as: poor,\<25% improvement; fair, 25%-50% improvement; good, 51%-75% improvement; and excellent, \>75% improvement.
percent of reduction in scar countup to 24 weekscount of the total and different types of acne scars was performed, before and after treatment on both sides of the face, and the percent of reduction was calculated
Patient satisfaction1 yearPatients will rate their overall satisfaction on a quartile grading system: 0, unsatisfied; 1, slightly satisfied; 2, satisfied; and 3, very satisfied
Adverse events1 yearerythema, edema, crusting, pigmentary changes, ecchymosis, and scarring, will be recorded

Countries

Egypt

Contacts

Primary Contactmohammed H Abdelhafez, MBBS
Dr.m.zayan@gmail.com+201099068855
Backup Contactsara M Awad, MD
saramawad@gmail.com+201023102094

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026